September 12, 2025 - 20:35

In a recent private meeting, the interim CEO and director of Kenvue, the company behind the popular pain reliever Tylenol, engaged in discussions with U.S. Health and Human Services Secretary Robert F. Kennedy Jr. The meeting aimed to address concerns regarding the potential association between the medication and autism. The CEO emphasized that scientific research has not established any clear link between the use of Tylenol and the development of autism spectrum disorders.
The dialogue comes amidst rising scrutiny and ongoing debates surrounding the safety of various medications during pregnancy and early childhood. The CEO's efforts appear to be focused on preventing the inclusion of Tylenol in a forthcoming report that could suggest a connection to autism, a point of contention that has garnered significant public interest and concern.
Both parties acknowledged the importance of continuing to review and analyze existing research to ensure public safety while addressing the anxieties of parents and caregivers.
February 15, 2026 - 06:00
California Sues as Trump Cuts $600M in Public Health Grants to Four StatesCalifornia Attorney General Rob Bonta has initiated a lawsuit against the federal government following a decision to rescind approximately $600 million in public health grants. The funding was...
February 14, 2026 - 02:02
A Little Dirt May Be a Big Boost for Children's HealthThe age-old advice to let kids get dirty is getting a scientific stamp of approval. Researchers are now pinpointing exactly how early exposure to certain microbes can build a stronger, more...
February 13, 2026 - 04:50
Opinion | DEI Is a Threat to Americans’ HealthA contentious debate over Diversity, Equity, and Inclusion (DEI) programs has entered the realm of American medical education and healthcare. Critics argue that an overemphasis on these initiatives...
February 12, 2026 - 07:07
Annual health checks could end 'fragmented' cerebral palsy careA new proposal suggests that introducing annual health checks for individuals with cerebral palsy could significantly improve their care and quality of life. The call aims to address what is often...